Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease

Brain Research

Volumn 1014, Issue 1-2, 2004, Pages 71-79

  González Deniselle, María Claudia ^a,b   Garay, Laura ^a,b   López Costa, Juan José ^b   González, Susana ^a,b   Mougel, Analía ^c   Guennoun, Rachida ^d   Schumacher, Michael ^d   De Nicola, Alejandro F ^a,b,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Argentina   (Argentina)

^d BICÊTRE HOSPITAL   (France)

Author keywords

Endocrine and autonomic regulation; Motoneuron disease; Neuroendocrine regulation: other; Neuroprotection; Nitric oxide synthase; Progesterone; Wobbler mouse

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 5ALPHA PREGNANE 3,20 DIONE; METHYLPREDNISOLONE; NITRIC OXIDE SYNTHASE; PROGESTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL VACUOLE; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; HISTOCHEMISTRY; MALE; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WHITE MATTER;

ANIMALS; ASTROCYTES; CELL COUNT; DOWN-REGULATION; FEMALE; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURON DISEASE; MOTOR NEURONS; NADPH DEHYDROGENASE; NITRIC OXIDE SYNTHASE; PROGESTERONE;

EID: 2942701786     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.004     Document Type: Article

References (43)

1. Abe K., Morita S., Kikuchi T., Itoyama Y. Protective effect of a novel free-radical scavenger, OPC-14117, on Wobbler mouse motor neuron disease. J. Neurosci. Res. 48:1997;63-70
2. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L.M., Melcangi R.C. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging. 24:2003;853-860
3. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochem. Biophys. Acta. 1366:1998;217-233
4. Boillée S., Peschanski M., Junier M.-P. The Wobbler mouse: a neurodegeneration jigsaw puzzle. Mol. Neurobiol. 28:2003;65-106
5. Clarke P.G.H. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181:1990;195-213
6. Clowry G.J., McHanwell S. Expression of nitric oxide synthase by motor neurons in the spinal cord of the mutant mouse Wobbler. Neurosci. Lett. 215:1996;177-180
7. Corvino V., Businaro R., Geloso M.C., Bigini P., Caballo V., Pompili E., Mennini T., Fumagalli L., Michetti F. S100B protein and 4-hydroxynonenal in the spinal cord of Wobbler mice. Neurochem. Res. 28:2003;341-345
8. Dave K.R., Bradley W.G., Pérez Pinzón M.A. Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse. Exp. Neurol. 182:2003;412-420
9. Desarnaud F., Do Thi A.M., Brown G., Lemke G., Suter U., Baulieu E.E., Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71:1998;1765-1768
10. González Deniselle M.C., Grillo C., González S., Roig P., De Nicola A.F. Evidence for down-regulation of GAP-43 mRNA in Wobbler mouse spinal motoneurons by corticosterone and a 21-aminosteroid. Brain Res. 841:1999;78-84
11. González Deniselle M.C., González S., Lima A., Wilkin G., De Nicola A.F. The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPHDiaphorase in the spinal cord of Wobbler mouse, a model for Amyotrophic Lateral Sclerosis. Neurochem. Res. 24:1999;1-8
12. González Deniselle M.C., González S., De Nicola A.F. Cellular basis of steroid neuroprotection in the Wobbler mouse, a model for motoneuron disease. Cell. Mol. Neurobiol. 21:2001;237-254
13. González Deniselle M.C., López Costa J.J., Pecci Saavedra J., Pietranera L., González S., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11:2002;457-468
14. González Deniselle M.C., López Costa J.J., González S., Labombarda F., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Basis of progesterone protection in spinal cord neurodegeneration. J. Steroid Biochem. Mol. Biol. 83:2003;199-209
15. Guang-Ping X., Dave K.R., Moraes C.T., Busto R., Sick T.J., Bradley W.G., Pérez-Pinzón M.A. Dysfunctional mitochondrial respiration in the Wobbler mouse brain. Neurosci. Lett. 300:2001;141-144
16. Gurney M.E. What transgenic mice tell us about neurodegenerative disease. BioEssays. 22:2000;297-304
17. Hall E.D. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell. Mol. Neurobiol. 13:1993;415-432
18. Hall E.D., Braughler J.M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and (Na, K)-ATPase activity. Dose response analysis during 1st hour after contusion injury in the cat. J. Neurosurg. 49:1982;563-568
19. Henderson J.T., Javaheri M., Kopko S., Roder J.C. Reduction of lower motor neuron degeneration in wobbler mice by n-acetyl-L-cysteine. J. Neurosci. 16:2000;7574-7582
20. Ikeda K., Iwasaki Y., Kinoshita M. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the Wobbler mouse. J. Neurol. Sci. 160:1988;9-15
21. Koenig H.L., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science. 268:1995;1500-1502
22. Kong J., Zu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:1998;3241-3250
23. Labombarda F., González S., Roig P., Lima A., Guennoun R., Schumacher M., De Nicola A.F. Modulation of NADPHDiaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured spinal cord. J. Steroid Biochem. Mol. Biol. 73:2000;159-169
24. Labombarda F., González S., González Deniselle M.C., Guennoun R., Schumacher M., De Nicola A.F. Cellular basis for progesterone neuroprotection in the injured spinal cord. J. Neurotrauma. 19:2002;343-355
25. Labombarda F., González S., González Deniselle M.C., Vinson G.P., Schumacher M., De Nicola A.F., Guennoun R. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25 Dx in the rat spinal cord. J. Neurochem. 87:2003;902-913
26. Lehmann A. Atlas Stereotaxique du Cerveau de la Souris. 1974;Editions du Centre National de la Recherche Scientifique, Paris
27. Melcangi R.C., Magnaghi V., Martini L. Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog. Neurobiol. 60:2000;291-308
28. Mitsumoto H., Bradley W.G. Murine motor neuron disease (the Wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain Res. 105:1982;811-834
29. Phul R.K., Shaw P.J., Ince P.G., Smith M.E. Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 4:2000;259-267
30. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:1991;481-487
31. Roof R., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects and progesterone. J. Neurotrauma. 17:2000;367-388
32. Roof R., Duvdevani R., Braswell L., Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129:1994;64-69
33. Roof R., Hoffman S., Stein D.G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol. Chem. Neuropathol. 31:1997;1-11
34. Rupprecht R., Reul J.M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgansberger W., Holsboer F. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 11:1993;523-530
35. Saravia F., González S., Roig P., Alves V., Homo-Delarche F., De Nicola A.F. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell. Mol. Neurobiol. 21:2001;15-27
36. Sasaki S., Warita H., Abe K., Iwata M. Neuronal nitric oxide synthase (nNos) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene. Acta Neuropathol. 103:2002;421-427
37. Schumacher M., Akwa I., Guennoun R., Robert F., Labombarda F., Desarnaud F., Robel P., De Nicola A.F., Baulieu E.E. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29:2000;307-326
38. Stein D.G., Fulop Z.L. Progesterone and recovery after traumatic brain injury: an overview. Neuroscientist. 4:1998;435-442
39. Stewart V.C., Heslegrave A.J., Brown G.C., Clark J.B., Heales J.R. Nitric-oxide dependent damage to neuronal mitochondria involves the NMDA receptor. Eur. J. Neurosci. 15:2002;458-464
40. Thomas A., Nockels R., Pan H., Shaffrey C., Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine. 24:1999;2134-2138
41. Tsuzaka K., Ishiyama T., Pioro E.P., Mitsumoto H. Role of brain-derived neurotrophic factor in Wobbler mouse motor neuron disease. Muscle Nerve. 24:2001;474-480
42. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784
43. Yung K.K.L., Tang F., Vacca-Galloway L.L. Changes of neuropeptides in spinal cord and brain stem of Wobbler mouse at different stages of motoneuron disease. Neuroscience. 50:1992;209-222